{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:41:06Z","timestamp":1790847666116,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2021630"],"award-info":[{"award-number":["BE2021630"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20180991"],"award-info":[{"award-number":["BK20180991"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","award":["JBGS202203"],"award-info":[{"award-number":["JBGS202203"]}],"id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.brainres.2023.148271","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T01:46:12Z","timestamp":1675734372000},"page":"148271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"1805","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6384-4361","authenticated-orcid":false,"given":"Shuai","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-3002","authenticated-orcid":false,"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-5798","authenticated-orcid":false,"given":"Guiyun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.brainres.2023.148271_b0005","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/mds.28779","article-title":"Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease","volume":"36","author":"Aamodt","year":"2021","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.brainres.2023.148271_b0010","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1212\/WNL.42.7.1315","article-title":"Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's disease","volume":"42","author":"Arai","year":"1992","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.brainres.2023.148271_b0015","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and Treatment of Parkinson Disease: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA : the journal of the American Medical Association"},{"issue":"7","key":"10.1016\/j.brainres.2023.148271_b0020","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1212\/WNL.0000000000010084","article-title":"NfL as a biomarker for neurodegeneration and survival in Parkinson disease","volume":"95","author":"B\u00e4ckstr\u00f6m","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.brainres.2023.148271_b0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-Beta (A\u03b2) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with A\u03b2 Pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2023.148271_b0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum","author":"Benedet","year":"2021","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.brainres.2023.148271_b0035","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3233\/JAD-200608","article-title":"Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration","volume":"77","author":"Benussi","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.brainres.2023.148271_b0040","doi-asserted-by":"crossref","unstructured":"Bastiaan R Bloem MSOC. Parkinson\u2019s disease. Lancet 2021.","DOI":"10.1016\/S0140-6736(21)00218-X"},{"issue":"6","key":"10.1016\/j.brainres.2023.148271_b0045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis","volume":"40","author":"Booth","year":"2017","journal-title":"Trends Neurosci"},{"issue":"3","key":"10.1016\/j.brainres.2023.148271_b0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","article-title":"Development of \u03b1-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease","volume":"114","author":"Braak","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.brainres.2023.148271_b0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2047-9158-2-20","article-title":"Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts","volume":"2","author":"Braidy","year":"2013","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.brainres.2023.148271_b0060","doi-asserted-by":"crossref","unstructured":"Brand\u00e3o PRP, Munhoz RP, Grippe TC, Cardoso FEC, de Almeida E Castro BM, Titze-de-Almeida R, et al. Cognitive impairment in Parkinson's disease: A clinical and pathophysiological overview. J Neurol Sci 2020;419:117177; 10.1016\/j.jns.2020.117177.","DOI":"10.1016\/j.jns.2020.117177"},{"issue":"24","key":"10.1016\/j.brainres.2023.148271_b0065","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1212\/WNL.0b013e318259e1c5","article-title":"Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study","volume":"78","author":"Carlesimo","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.brainres.2023.148271_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"30","key":"10.1016\/j.brainres.2023.148271_b0075","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.1073\/pnas.1700239114","article-title":"Monomeric and fibrillar \u03b1-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of A\u03b242 aggregates","volume":"114","author":"Chia","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7","key":"10.1016\/j.brainres.2023.148271_b0080","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/aws133","article-title":"Alterations in axonal transport motor proteins in sporadic and experimental Parkinson\u2019s disease","volume":"135","author":"Chu","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2023.148271_b0085","doi-asserted-by":"crossref","unstructured":"Chung C, Chan L, Chen J, Bamodu OA, Hong C. Neurofilament light chain level in plasma extracellular vesicles and Parkinson\u2019s disease. Ther Adv Neurol Disord 2020;13:1160570441; 10.1177\/1756286420975917.","DOI":"10.1177\/1756286420975917"},{"issue":"1","key":"10.1016\/j.brainres.2023.148271_b0090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.brainres.2023.148271_b0095","doi-asserted-by":"crossref","first-page":"e12937","DOI":"10.1111\/acel.12937","article-title":"Astrocyte senescence: Evidence and significance","volume":"18","author":"Cohen","year":"2019","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.brainres.2023.148271_b0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JPD-202323","article-title":"Neuropathological and Biomarker Findings in Parkinson\u2019s Disease and Alzheimer\u2019s Disease: From Protein Aggregates to Synaptic Dysfunction","volume":"11","author":"Compta","year":"2021","journal-title":"Journal of Parkinson's Disease"},{"key":"10.1016\/j.brainres.2023.148271_b0105","article-title":"Parkinson disease-associated cognitive impairment","author":"Dag Aarsland","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.brainres.2023.148271_b0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mds.26312","article-title":"Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?","volume":"31","author":"Duncan","year":"2016","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.brainres.2023.148271_b0115","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.brainres.2023.148271_b0120","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"15","key":"10.1016\/j.brainres.2023.148271_b0125","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.brainres.2023.148271_b0130","doi-asserted-by":"crossref","unstructured":"Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, et al. Blood-based NfL A biomarker for differential diagnosis of parkinsonian disorder. Neurology 2017;88 (10):930-37; 10.1212\/WNL.0000000000003680.","DOI":"10.1212\/WNL.0000000000003680"},{"issue":"3","key":"10.1016\/j.brainres.2023.148271_b0135","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hbm.21245","article-title":"Cognitive status correlates with white matter alteration in Parkinson's disease","volume":"33","author":"Hattori","year":"2012","journal-title":"Hum Brain Mapp"},{"issue":"7","key":"10.1016\/j.brainres.2023.148271_b0140","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s10571-019-00696-2","article-title":"Enhancing the Astrocytic Clearance of Extracellular \u03b1-Synuclein Aggregates by Ginkgolides Attenuates Neural Cell Injury","volume":"39","author":"Hua","year":"2019","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.brainres.2023.148271_b0145","doi-asserted-by":"crossref","unstructured":"Kam T, Hinkle JT, Dawson TM, Dawson VL. Microglia and astrocyte dysfunction in parkinson's disease. Neurobiol Dis 2020;144:105028; 10.1016\/j.nbd.2020.105028.","DOI":"10.1016\/j.nbd.2020.105028"},{"issue":"8","key":"10.1016\/j.brainres.2023.148271_b0150","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.brainres.2023.148271_b0155","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct Transfer of \u03b1-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.brainres.2023.148271_b0160","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/glia.23734","article-title":"Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes","volume":"68","author":"Li","year":"2020","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.brainres.2023.148271_b0165","doi-asserted-by":"crossref","first-page":"17368","DOI":"10.1038\/s41598-018-35766-w","article-title":"Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease","volume":"8","author":"Lin","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.brainres.2023.148271_b0170","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL-A biomarker for disease severity and progression in Parkinson disease","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.brainres.2023.148271_b0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.brainres.2023.148271_b0180","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JPD-212535","article-title":"Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson\u2019s Disease","volume":"11","author":"Ma","year":"2021","journal-title":"Journal of Parkinson's Disease"},{"issue":"13","key":"10.1016\/j.brainres.2023.148271_b0185","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1212\/WNL.0000000000007179","article-title":"Serum NFL discriminates Parkinson disease from atypical parkinsonisms","volume":"92","author":"Marques","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2023.148271_b0190","first-page":"12","volume":"9","author":"Miyazaki","year":"2020","journal-title":"Neuron-Astrocyte Interactions in Parkinson's Disease. Cells"},{"issue":"11","key":"10.1016\/j.brainres.2023.148271_b0195","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.brainres.2023.148271_b0200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/mds.27897","article-title":"CSF or Serum Neurofilament Light Added to \u03b1-Synuclein Panel Discriminates Parkinson's From Controls","volume":"35","author":"Oosterveld","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.brainres.2023.148271_b0205","doi-asserted-by":"crossref","unstructured":"Osborn LM, Kamphuis W, Wadman WJ, Hol EM. Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease. Prog Neurobiol 2016;144:121-41; 10.1016\/j.pneurobio.2016.01.001.","DOI":"10.1016\/j.pneurobio.2016.01.001"},{"key":"10.1016\/j.brainres.2023.148271_b0215","doi-asserted-by":"crossref","unstructured":"Pilotto A, Imarisio A, Conforti F, Scalvini A, Masciocchi S, Nocivelli S, et al. Plasma NfL, clinical subtypes and motor progression in Parkinson's disease. Parkinsonism Relat Disord 2021;87:41-47; 10.1016\/j.parkreldis.2021.04.016.","DOI":"10.1016\/j.parkreldis.2021.04.016"},{"issue":"11","key":"10.1016\/j.brainres.2023.148271_b0210","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.brainres.2023.148271_b0220","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.brainres.2023.148271_b0225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12974-021-02158-3","article-title":"Crosstalk between astrocytes and microglia results in increased degradation of [alpha]-synuclein and amyloid-[beta] aggregates","volume":"18","author":"Rostami","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.brainres.2023.148271_b0230","doi-asserted-by":"crossref","unstructured":"Sampedro F, P\u00e9rez-Gonz\u00e1lez R, Mart\u00ednez-Horta S, Mar\u00edn-Lahoz J, Pagonabarraga J, Kulisevsky J. Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease. Parkinsonism Relat Disord 2020;74:43-49; 10.1016\/j.parkreldis.2020.04.009.","DOI":"10.1016\/j.parkreldis.2020.04.009"},{"key":"10.1016\/j.brainres.2023.148271_b0235","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28738","article-title":"Systematic Assessment of 10 Biomarker Candidates Focusing on alpha-Synuclein-Related Disorders","author":"Schulz","year":"2021","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.brainres.2023.148271_b0240","first-page":"2019","article-title":"Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"10","key":"10.1016\/j.brainres.2023.148271_b0245","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/NEN.0b013e3181b66f1b","article-title":"Degeneration in Different Parkinsonian Syndromes Relates to Astrocyte Type and Astrocyte Protein Expression","volume":"68","author":"Song","year":"2009","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"10.1016\/j.brainres.2023.148271_b0250","doi-asserted-by":"crossref","unstructured":"Su W, Chen HB, Li SH, Wu DY. Correlational study of the serum levels of the glial fibrillary acidic protein and neurofilament proteins in Parkinson's disease patients. Clin Neurol Neurosurg 2012;114 (4):372-75; 10.1016\/j.clineuro.2011.11.002.","DOI":"10.1016\/j.clineuro.2011.11.002"},{"issue":"1","key":"10.1016\/j.brainres.2023.148271_b0255","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta(1\u201342\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimers Res Ther"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899323000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899323000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:23:16Z","timestamp":1757787796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899323000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":51,"alternative-id":["S0006899323000410"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2023.148271","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2023.148271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"148271"}}